These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3531954)

  • 1. Elevated pancreatic oncofetal antigen levels measured by enzyme immunoassay in pure pancreatic juice of patients with pancreatic cancer.
    Nishida K; Yoshikawa T; Fukumoto K; Kondo M
    Oncology; 1986; 43(5):311-5. PubMed ID: 3531954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of pancreatic oncofetal antigen (POA) in the diagnosis of pancreatic cancer].
    Nishida K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):601-8. PubMed ID: 6349542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.
    Nishida K; Tasaki N; Miyagawa H; Yoshikawa T; Kondo M
    Am J Gastroenterol; 1988 Feb; 83(2):126-9. PubMed ID: 3422536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme immunoassay of pancreatic oncofetal antigen (POA) as a marker of pancreatic cancer.
    Nishida K; Sugiura M; Yoshikawa T; Kondo M
    Gut; 1985 May; 26(5):450-5. PubMed ID: 3888788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of pancreatic cancer by pancreatic oncofetal antigen (poa) in pure pancreatic juice.
    Nishida K; Kondo M; Jessen K; Classen M
    Hepatogastroenterology; 1981 Apr; 28(2):102-5. PubMed ID: 7216142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pancreatic oncofetal antigen (POA): its characterization and application for enzyme immunoassay.
    Oguchi H; Homma T; Kawa S; Nagata A; Furuta S; Fukui H
    Cancer Detect Prev; 1984; 7(1):51-8. PubMed ID: 6367984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pancreatic oncofetal antigen (POA) and carcinoma of the pancreas].
    Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
    Gan No Rinsho; 1984 May; 30(6 Suppl):558-62. PubMed ID: 6205174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic markers of pancreatic cancer in humans].
    Kulagin PP; Chalov VV
    Vopr Onkol; 1983; 29(8):62-7. PubMed ID: 6193639
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
    Schmiegel WH; Eberl W; Kreiker C; Kalthoff H; Bützow GH; Jessen K; Klapdor R; Soehendra N; Wargenau M; Classen M
    Hepatogastroenterology; 1985 Jun; 32(3):141-5. PubMed ID: 2410346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of the enzyme immunoassay for pancreatic oncofetal antigen.
    Kawa S; Homma T; Oguchi H; Nagata A; Furuta S; Usuda N; Nagata T; Fukui H
    Ann N Y Acad Sci; 1983; 417():400-9. PubMed ID: 6367597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biohumeral markers in the diagnosis of pancreatic carcinoma].
    Panucci A; Del Favero G; Falmis C; Brosolo P; Basso D; Pedrazzoli S; Baccaglini U; Marchioro L; Bonvilini P; Naccarato R
    Recenti Prog Med; 1985; 76(7-8):385-91. PubMed ID: 3865269
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oncofetal antigen].
    Nishida K; Yoshikawa T; Kondo M
    Nihon Rinsho; 1980; 38(1):152-60. PubMed ID: 6156250
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological diagnosis of pancreatic cancer by assaying carcinoembryonic antigen (CEA) in pure pancreatic juice.
    Nishida K; Yoshikawa T; Kondo M; Thiele HG
    Hepatogastroenterology; 1980 Dec; 27(6):488-94. PubMed ID: 7203382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum pancreatic oncofetal antigen: its clinical usefulness for screening pancreatic cancer in combination with tests for other tumor markers.
    Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
    Gastroenterol Jpn; 1983 Oct; 18(5):487-91. PubMed ID: 6197338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) in sera and pancreatic juice in the diagnosis of pancreatic cancer.
    Lin JT; Wang TH; Chen DS; Sung JL
    Taiwan Yi Xue Hui Za Zhi; 1987 Aug; 86(8):823-8. PubMed ID: 3479516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pancreatic oncofetal antigen (POA)].
    Mugitani H; Furue H; Kako M; Hirota F; Fuse K; Takahashi T; Sakamoto K; Yamada K; Suminaga M; Ezaki M; Judo R
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1737-43. PubMed ID: 6882002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of enzyme immunoassay for a pancreatic oncofetal antigen (POA)].
    Hishinuma S; Takami H; Shintoku J; Matsui J; Uematsu S; Baba H; Ogata Y; Abe O; Ishii T; Miyoshi K
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2217-24. PubMed ID: 6398349
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages.
    Matsumoto S; Harada H; Tanaka J; Ochi K; Seno T; Tsurumi T; Kunichika K
    Pancreas; 1994 Nov; 9(6):741-7. PubMed ID: 7846018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on a pancreatic oncofetal antigen (POA) in patients with pancreatic cancer].
    Hishnuma S
    Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1449-60. PubMed ID: 3785134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of enzyme immunoassay for pancreatic oncofetal antigen (POA) (author's transl)].
    Nishida K; Fukumoto K; Takemura S; Yoshikawa T; Kondo M
    Nihon Shokakibyo Gakkai Zasshi; 1981 Apr; 78(4):909-13. PubMed ID: 7024591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.